Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: A retrospective assessment

Digestive and Liver Disease

Volumn 46, Issue 12, 2014, Pages 1086-1092

  Regnault, Helene ^a   Bourrier, Anne ^a   Lalande, Valerie ^a   Nion Larmurier, Isabelle ^a   Sokol, Harry ^a   Seksik, Philippe ^a   Barbut, Frederic ^b   Cosnes, Jacques ^a   Beaugerie, Laurent ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b National Reference Laboratory for Clostridium difficile   (France)

Author keywords

Clostridium difficile infection; Inflammatory bowel disease; Nonsteroidal anti inflammatory drugs

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CROHN DISEASE; CYTOTOXICITY ASSAY; DISEASE ASSOCIATION; FECES ANALYSIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; ULCERATIVE COLITIS; CLOSTRIDIUM INFECTIONS; COMPLICATION; HOSPITALIZATION; INFLAMMATORY BOWEL DISEASES; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84938487936     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.09.003     Document Type: Article

References (35)

1. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. New England Journal of Medicine 2002, 346:334-339.
2. Johnson S., Gerding D.N. Clostridium difficile - associated diarrhea. Clinical Infectious Diseases 1998, 26:1027-1034. quiz 35-6.
3. McDonald L.C., Owings M., Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerging Infectious Diseases 2006, 12:409-415.
4. Barbut F., Petit J.C. Epidemiology of Clostridium difficile-associated infections. Clinical Microbiology and Infection 2001, 7:405-410.
5. Dubberke E.R., Wertheimer A.I. Review of current literature on the economic burden of Clostridium difficile infection. Infection Control and Hospital Epidemiology 2009, 30:57-66.
6. Ananthakrishnan A.N. Clostridium difficile infection: epidemiology, risk factors and management. Nature Reviews Gastroenterology and Hepatology 2011, 8:17-26.
7. Yanai H., Nguyen G.C., Yun L., et al. Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with Clostridium difficile: antibiotics alone or combined antibiotics/immunomodulators. Inflammatory Bowel Diseases 2011, 17:1540-1546.
8. Issa M., Vijayapal A., Graham M.B., et al. Impact of Clostridium difficile on inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2007, 5:345-351.
9. Ananthakrishnan A.N., McGinley E.L., Binion D.G. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008, 57:205-210.
10. Ananthakrishnan A.N., McGinley E.L., Saeian K., et al. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2011, 17:976-983.
11. Nguyen G.C., Kaplan G.G., Harris M.L., et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. American Journal of Gastroenterology 2008, 103:1443-1450.
12. Rodemann J.F., Dubberke E.R., Reske K.A., et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2007, 5:339-344.
13. Fried L., Bernardini J., Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. American Journal of Kidney Diseases 2001, 37:337-342.
14. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infection Control and Hospital Epidemiology 2010, 31:431-455.
15. Crobach M.J., Dekkers O.M., Wilcox M.H., et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clinical Microbiology and Infection 2009, 15:1053-1066.
16. Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet 1980, 1:514.
17. Lichtiger S., Present D.H., Kornbluth A., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. New England Journal of Medicine 1994, 330:1841-1845.
18. Gerding D.N., Johnson S., Peterson L.R., et al. Clostridium difficile-associated diarrhea and colitis. Infection Control and Hospital Epidemiology 1995, 16:459-477.
19. Clayton E.M., Rea M.C., Shanahan F., et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. American Journal of Gastroenterology 2009, 104:1162-1169.
20. Goodhand J.R., Alazawi W., Rampton D.S. Systematic review: Clostridium difficile and inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2011, 33:428-441.
21. Ricciardi R., Ogilvie J.W., Roberts P.L., et al. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Diseases of the Colon and Rectum 2009, 52:40-45.
22. Vane J.R., Mitchell J.A., Appleton I., et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:2046-2050.
23. Thiefin G., Beaugerie L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine 2005, 72:286-294.
24. Etienney I., Beaugerie L., Viboud C., et al. Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut 2003, 52:260-263.
25. Tanner A.R., Raghunath A.S. Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. Digestion 1988, 41:116-120.
26. Gibson G.R., Whitacre E.B., Ricotti C.A. Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. Archives of Internal Medicine 1992, 152:625-632.
27. Evans J.M., McMahon A.D., Murray F.E., et al. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997, 40:619-622.
28. Felder J.B., Korelitz B.I., Rajapakse R., et al. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. American Journal of Gastroenterology 2000, 95:1949-1954.
29. Kaufmann H.J., Taubin H.L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Annals of Internal Medicine 1987, 107:513-516.
30. Bonner G.F., Walczak M., Kitchen L., et al. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease. American Journal of Gastroenterology 2000, 95:1946-1948.
31. Takeuchi K., Smale S., Premchand P., et al. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2006, 4:196-202.
32. Hanauer S.B., Sandborn W. Practice Parameters Committee of the American College of G. Management of Crohn's disease in adults. American Journal of Gastroenterology 2001, 96:635-643.
33. McFarland L.V., Mulligan M.E., Kwok R.Y., et al. Nosocomial acquisition of Clostridium difficile infection. New England Journal of Medicine 1989, 320:204-210.
34. Bossuyt P., Verhaegen J., Van Assche G., et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. Journal of Crohn's and Colitis 2009, 3:4-7.
35. Dial S., Delaney J.A., Barkun A.N., et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. Journal of the American Medical Association 2005, 294:2989-2995.